Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Prepaid Assets (2016 - 2026)

Cytosorbents filings provide 16 years of Prepaid Assets readings, the most recent being $1.6 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 52.49% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 52.49% decrease, with the full-year FY2025 number at $1.6 million, down 52.49% from a year prior.
  • Prepaid Assets hit $1.6 million in Q4 2025 for Cytosorbents, down from $2.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.3 million in Q4 2024 to a low of $880363.0 in Q1 2024.
  • Median Prepaid Assets over the past 5 years was $1.8 million (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Prepaid Assets: crashed 52.75% in 2024 and later surged 256.3% in 2025.
  • Cytosorbents' Prepaid Assets stood at $2.9 million in 2021, then decreased by 13.34% to $2.5 million in 2022, then fell by 26.28% to $1.8 million in 2023, then soared by 78.31% to $3.3 million in 2024, then crashed by 52.49% to $1.6 million in 2025.
  • The last three reported values for Prepaid Assets were $1.6 million (Q4 2025), $2.3 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.